Prevalence and Profile of Aspirin Resistance in Hemodialysis Patients

Aspirin Resistance Clinical Trial

Official title:

Prevalence of Aspirin Resistance in Hemodialysis Patients

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00792272
• Other study ID #: 08-013
• Status: Completed
• Phase: N/A
• First received: November 14, 2008
• Last updated: July 19, 2013
• Start date: June 2008
• Est. completion date: November 2008

Study information

• Verified date: July 2013
• Source: Northwell Health
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Dialysis patient could be more aspirin resistant than the general population based on data from chronic kidney disease patients

Description:

We will try to describe the profile of aspirin resistant patient in hemodialysis patients

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: November 2008
• Est. primary completion date: November 2008
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• all hemodialysis patients on aspirin

Exclusion Criteria:

• low platelets <100.000

• coagulopathy, bleeding disorders

• patient on plavix

Study Design

Observational Model: Case Control, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Aspirin Resistance

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Northwell Health	Staten Island University Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Aspirin Resistance in Hemodialysis patients		2 months	No